|
1
|
Evidence that some patients with pernicious anemia are not recognized by radiodilution assay for cobalamin in serum.
|
N Engl J Med
|
1978
|
2.05
|
|
2
|
Cloning of human cDNAs encoding mitochondrial and cytosolic serine hydroxymethyltransferases and chromosomal localization.
|
J Biol Chem
|
1993
|
1.42
|
|
3
|
Absorption of unaltered folic acid from the gastro-intestinal tract in man.
|
Br J Haematol
|
1967
|
1.26
|
|
4
|
Prolonged inhibition of DNA synthesis associated with the accumulation of methotrexate polyglutamates by cultured human cells.
|
Mol Pharmacol
|
1978
|
1.12
|
|
5
|
Intestinal conversion of folinic acid to 5-methyltetrahydrofolate in man.
|
Br J Haematol
|
1972
|
1.04
|
|
6
|
Homeostasis of folic acid in patients undergoing maintenance hemodialysis.
|
N Engl J Med
|
1968
|
1.03
|
|
7
|
Synthesis of methotrexate polyglutamates in cultured human cells.
|
Mol Pharmacol
|
1978
|
1.01
|
|
8
|
Cobalamin and folate deficiency: acquired and hereditary disorders in children.
|
Semin Hematol
|
1999
|
0.98
|
|
9
|
Tissue-specific synthesis of methotrexate polyglutamates in the rat.
|
Cancer Res
|
1975
|
0.97
|
|
10
|
Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
|
Cancer Res
|
1977
|
0.96
|
|
11
|
Retinoblastoma: the case for radiotherapy and for adjuvant chemotherapy.
|
Cancer
|
1980
|
0.85
|
|
12
|
The indentification of foetal antigens in human bone marrow cells.
|
Differentiation
|
1974
|
0.85
|
|
13
|
Synthesis of methotrexate polyglutamates by bone marrow cells from patients with leukemia and lymphoma.
|
Dev Pharmacol Ther
|
1980
|
0.83
|
|
14
|
High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia.
|
Blood
|
1993
|
0.82
|
|
15
|
Methotrexate and folate content of erythrocytes in patients receiving oral vs intramuscular therapy with methotrexate.
|
J Pediatr
|
1984
|
0.81
|
|
16
|
Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.
|
Clin Cancer Res
|
1996
|
0.80
|
|
17
|
Computed tomography brain scans in long term survivors of childhood acute lymphoblastic leukemia.
|
Med Pediatr Oncol
|
1981
|
0.79
|
|
18
|
Polygammaglutamyl metabolites of folic acid in human liver.
|
Lancet
|
1973
|
0.78
|
|
19
|
Letter: Cancer treatment needs better antiemetics.
|
N Engl J Med
|
1975
|
0.78
|
|
20
|
Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study.
|
Cancer Chemother Pharmacol
|
1992
|
0.78
|
|
21
|
Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study.
|
Cancer
|
1993
|
0.78
|
|
22
|
Methotrexate polyglutamates in cultured human cells.
|
Adv Exp Med Biol
|
1983
|
0.77
|
|
23
|
Methotrexate metabolism by bone marrow cells from patients with leukemia.
|
Adv Exp Med Biol
|
1983
|
0.77
|
|
24
|
Lack of dihydrofolate reductase in human tumor and leukemia cells in vivo.
|
Cancer Drug Deliv
|
1985
|
0.77
|
|
25
|
Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
|
Mol Pharmacol
|
1982
|
0.76
|
|
26
|
A phase I study of acivicin in refractory pediatric solid tumors. A Pediatric Oncology Group study.
|
Invest New Drugs
|
1995
|
0.76
|
|
27
|
Recombinant interferon alfa given before and in combination with standard chemotherapy in children with acute lymphoblastic leukemia in first marrow relapse: a Pediatric Oncology Group pilot study.
|
J Clin Oncol
|
1991
|
0.76
|
|
28
|
Folic acid supplementation and neural tube defects.
|
Clin Invest Med
|
1994
|
0.75
|
|
29
|
Editorial: Paroxysmal nocturnal hemoblobinuria.
|
Can Med Assoc J
|
1973
|
0.75
|
|
30
|
Folate deficiency and formiminoglutamic acid excretion during chronic diethylnitrosamine administration to rats.
|
Cancer Res
|
1973
|
0.75
|
|
31
|
Measurements of red blood cell methotrexate concentrations and lymphocyte subsets during therapy of rheumatoid arthritis.
|
Clin Exp Rheumatol
|
1985
|
0.75
|
|
32
|
Phase I study of a 120-hour continuous intravenous infusion of 5-fluorouracil in pediatric patients with recurrent solid tumors: a Pediatric Oncology Group study.
|
Med Pediatr Oncol
|
1990
|
0.75
|
|
33
|
A phase I trial of fazarabine in refractory pediatric solid tumors. A Pediatric Oncology Group study.
|
Invest New Drugs
|
1993
|
0.75
|
|
34
|
Inhibition of gamma-glutamyl hydrolases in human cells by 2-mercaptomethylglutaric acid.
|
Biochem Biophys Res Commun
|
1987
|
0.75
|
|
35
|
Osteogenic sarcoma following treatment with megavoltage radiation and chemotherapy for bone tumors in children.
|
Med Pediatr Oncol
|
1980
|
0.75
|
|
36
|
Phase II study of 13-cis-retinoic acid in pediatric patients with acute nonlymphocytic leukemia--a Pediatric Oncology Group study.
|
J Immunother (1991)
|
1991
|
0.75
|
|
37
|
Delay in metabolism of parenteral folinic acid to 5-methyltetrahydrofolate in man.
|
Biochem Soc Trans
|
1976
|
0.75
|
|
38
|
Absorption of folic acid.
|
Lancet
|
1972
|
0.75
|
|
39
|
Response to folinic acid in B 12 -deficiency anaemia.
|
Lancet
|
1971
|
0.75
|
|
40
|
Chemotherapy of childhood acute lymphoblastic leukemia.
|
Dev Pharmacol Ther
|
1986
|
0.75
|
|
41
|
Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
|
J Natl Cancer Inst
|
1990
|
0.75
|
|
42
|
Significance of a (4;11) translocation in acute lymphoblastic leukemia.
|
Cancer
|
1982
|
0.75
|
|
43
|
Inhibition of methotrexate polyglutamate accumulation in cultured human cells.
|
Mol Pharmacol
|
1981
|
0.75
|
|
44
|
Hepatic failure secondary to indicine N-oxide toxicity. A Pediatric Oncology Group Study.
|
Cancer
|
1983
|
0.75
|
|
45
|
Methotrexate metabolism in mutant Chinese hamster ovary cells lacking dihydrofolate reductase.
|
Biochem Pharmacol
|
1987
|
0.75
|
|
46
|
Rhabdomyosarcoma of the brain.
|
Can J Surg
|
1980
|
0.75
|